Nephrocare Health Services acquires Philippine dialysis center for PhP 71.8 million

1 min read     Updated on 13 Aug 2026, 11:37 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Nephrocare Health Services Limited’s Philippine subsidiary acquired dialysis assets in Davao City for PhP 71.8 million. The deal with Juan Nephro Dialysis Center is not a related-party transaction and involves no share issuance or special rights.

powered bylight_fuzz_icon
48146818

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services expanded its international footprint with the acquisition of dialysis center assets in the Philippines. The company’s overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services Philippines Inc., entered into an Asset Transfer Agreement dated August 12, 2026, to purchase identified assets from Juan Nephro Dialysis Center.

The transaction value stands at PhP 71,800,000 (Philippine Pesos Seventy-One Million Eight Hundred Thousand Pesos Only). The acquired assets relate to a dialysis center located in Davao City, Davao Del Sur, Philippines.

Transaction Details

The deal was structured as an asset purchase rather than a share acquisition. According to the disclosure made to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, there are no special rights attached to the agreement, such as director appointments or subscription rights.

Particulars Details
Purchaser Nephrocare Health Care Services Philippines Inc.
Seller Juan Nephro Dialysis Center
Consideration PhP 71,800,000
Asset Location Davao City, Philippines
Related Party? No

The seller is not related to the promoter group or group companies of Nephrocare Health Services. Consequently, the transaction does not fall within the scope of related-party transactions and was executed at arm’s length.

Regulatory Disclosure

Nephrocare Health Services Limited issued the disclosure pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company confirmed that no shares were issued as part of this agreement, and no loan facilities were involved in the transaction structure.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.66%-2.75%+7.72%+20.02%+46.50%+46.50%

How does this acquisition impact Nephrocare's projected revenue growth and EBITDA margins from its international operations in the coming fiscal year?

What are the company's specific integration strategies for the Davao City center to ensure operational synergy with its existing Philippine network?

Does this asset purchase signal a broader strategic shift towards aggressive expansion in Southeast Asian markets, and if so, which other countries are on the radar?

Nephrocare Health Services
View Company Insights
View All News
like17
dislike

Nephrocare Q1 Results: Audio of Q1FY27 earnings call released

0 min read     Updated on 12 Aug 2026, 10:21 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Nephrocare Health Services Limited released the audio of its Q1FY27 earnings call held on August 12, 2026. The recording covers unaudited standalone and consolidated results for the quarter ended June 30, 2026. The disclosure complies with SEBI LODR Regulations 30 and 46(2).

powered bylight_fuzz_icon
48099079

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services Limited has uploaded the audio recording of its investors' conference call regarding the first quarter of FY27 financial results. The session took place on August 12, 2026, and addressed the unaudited standalone and consolidated performance for the period ended June 30, 2026.

The disclosure was made in compliance with Regulation 30, Regulation 46(2), and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Call Details

The audio recording is accessible via the company's official website at www.nephroplus.com . This release serves as a continuation of the earlier communication dated July 24, 2026, which likely contained the written financial statements or a notice regarding the upcoming discussion.

Kishore Kathri, Company Secretary and Head Legal at Nephrocare, signed the disclosure letter. The document confirms that the recording is available for public record, ensuring transparency for investors and analysts reviewing the quarterly performance.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.66%-2.75%+7.72%+20.02%+46.50%+46.50%

How will the Q1 FY27 performance influence Nephrocare's guidance for full-year revenue and EBITDA margins?

What is the projected timeline for new dialysis center expansions in tier-2 and tier-3 cities following this quarter's results?

Are there any anticipated changes in reimbursement policies from government schemes that could impact patient acquisition costs in FY27?

Nephrocare Health Services
View Company Insights
View All News
like17
dislike

More News on Nephrocare Health Services

1 Year Returns:+46.50%